GlassScriptPhysician profile
Raj A Patel
NPI 1720379712
$2,476.02
in general payments reported to CMS, 2019-2025
21 companies · $34.65 in 2025
The $34.65 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $42.08 · 2021: $347 · 2022: $672 · 2023: $303 · 2024: $445 · 2025: $34.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,443.85 | 2020-2025 | Puraply, Affinity, Cygnus Dual |
| Mayne Pharma Commercial LLC | $188.64 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $154.07 | 2019 | |
| Dexcom, INC. | $95.20 | 2021-2024 | Dexcom G6 Transmitter |
| Ucb, INC. | $79.15 | 2019 | |
| Genzyme Corporation | $68.21 | 2019-2022 | |
| Genentech USA, INC. | $62.47 | 2022 | |
| Janssen Biotech, INC. | $58.56 | 2022 | |
| Aclaris Therapeutics, INC. | $51.09 | 2019 | |
| Abbvie INC. | $50.77 | 2022 | |
| Leo Pharma INC. | $36.42 | 2019 | |
| Pfizer INC. | $25.79 | 2019 | |
| Sun Pharmaceutical Industries INC. | $21.74 | 2022 | |
| Amgen INC. | $20.44 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $20.35 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $20.21 | 2024 | Ycanth |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.30 | 2020 | |
| Epi Health, LLC | $17.86 | 2022 | |
| Lilly USA, LLC | $16.95 | 2022 | |
| Abiomed | $13.63 | 2021 | |
| Galderma Laboratories, L.P. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.